Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)

ACCL 4.000

-1.2%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: david thor who wrote (95)	6/24/1998 11:14:00 PM
From: david thor	Read Replies (1) of 179

Finally, here's the news we were, I guess, looking for. I'd like to know more behind the reasoning, but a summary is all I could find. I suppose it does set the stage for PCOP to outperform. I'd like to see more than just one analysis, though, and the full text of this one. It did seem to be a rather large estimate cut, although a 12-month goal of 23 would hardly seem to be the sole reason to pull back from around 17. Pharmacopeia Inc Maintained 'Strong Buy' at BT Alex. Brown Princeton, New Jersey, June 24 (Bloomberg Data) -- Pharmacopeia Inc. (PCOP US) was maintained ''strong buy'' by analyst Kevin C. Tang at BT Alex. Brown Incorporated. Tang cut his 12-month price target to $23 from $32 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next